Phenotype/Genotype Correlations in Movement Disorders
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal of this protocol is to identify families with inherited movement disorders and evaluate disease manifestations to establish an accurate clinical diagnosis by using newest technological advances and investigate the underlying molecular mechanisms. Studies of inherited movement disorders in large families with good genealogical records are especially valuable. Patients with diseases of known molecular basis will be genotyped in order to investigate phenotype/genotype correlation. Patients with disease of unknown or incomplete genetic characterization will be studied with a hope of contributing to the identification of specific disease-causing genes and genetic mechanisms responsible for a specific disorder.
| Condition |
|---|
|
Movement Disorder |
| Study Type: | Observational |
| Official Title: | Phenotype/Genotype Correlations in Movement Disorders |
| Estimated Enrollment: | 1000 |
| Study Start Date: | July 2001 |
Objective
The goal of this protocol is to identify families with inherited movement disorders and evaluate disease manifestations to establish an accurate clinical diagnosis, and to investigate the underlying molecular mechanisms. Studies of inherited movement disorders in large families with good genealogical records are especially valuable.
Additionally, we plan to screen subjects with and without Parkinson's disease for the presence of revelant antibodies, such as antibodies targeting tobacco mosaic virus antigens which may have a protective role against the development of the disease or may be related to other pathophysiologic mechanisms.
Study population
Subjects older than 2 years old with movement disorders and their family members will be enrolled. Patients with diseases of known molecular basis will be genotyped in order to investigate phenotype/genotype correlation. Patients with disease of unknown or incomplete genetic characterization will be studied with a hope of contributing to the identification of specific disease causing genes and genetic mechanisms involved in a particular disorder.
Design
Eligible participants will have an initial medical and/or neurological evaluation at the Clinical Center or in the field, including blood draw for genetic testing.
Outcome measure
Determination of phenotype/genotype correlations in specific movement disorders, gene identification if not known, presence of antibodies in Parkinson's disease and establishment of a clinical diagnosis when possible.
Eligibility| Ages Eligible for Study: | 2 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
Individuals with known or suspected inherited movement disorders.
Family members of movement disorders patients
EXCLUSION CRITERIA:
Pregnant women will be excluded from MRI or X-ray studies
Children less than 2 years of age
Those who cannot provide their own consent or appoint a Durable Power of Attorney (DPA)
Contacts and Locations| Contact: Elaine P Considine, R.N. | (301) 435-8518 | considinee@ninds.nih.gov |
| Contact: Codrin I Lungu, M.D. | (301) 402-0976 | lunguci@ninds.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov | |
| Principal Investigator: | Codrin I Lungu, M.D. | National Institute of Neurological Disorders and Stroke (NINDS) |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00018889 History of Changes |
| Other Study ID Numbers: | 010206, 01-N-0206 |
| Study First Received: | July 7, 2001 |
| Last Updated: | May 23, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Clinical Evaluation Genetic Study Essential Tremor Familial Myoclonus |
Hereditary Ataxia Movement Disorder Inherited Movement Disorder |
Additional relevant MeSH terms:
|
Movement Disorders Central Nervous System Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013